In March, the drugmakers said the vaccine was found to be safe, effective and produced robust antibody responses in 12- to 15-year olds in a clinical trial.
Pfizer, BioNTech ask U.S. to allow COVID-19 vaccine emergency use in adolescents
© The Crystal Eyes